REPORT ID 7139

Global Blood-Brain Barrier Transport Drugs Market Research Report 2017

Publish Date
2-Nov-17
Pages
116
Format
Electronic (PDF)

In this report, the global Blood-Brain Barrier Transport Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Blood-Brain Barrier Transport Drugs in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Blood-Brain Barrier Transport Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Cyclenium
    BioAdvance
    EIP Pharma
    Bioasis
    Immune Pharmaceuticals
    AZ Therapies
    Palobiofarma
    Bach Pharma
    BrainsGate
    CarThera
    Dainippon Sumitomo Pharma
    Fluorinov Pharma
    Fondazione Telethon
    Minoryx
    NewGen Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Carrier-mediated Transport
    Receptor-mediated Transport
    Absorptive-mediated Transport
    Active Efflux Transport
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Alzheimer's Disease
    Epilepsy
    Parkinson's Disease
    Multiple Sclerosis
    Hunter's Syndrome
    Brain Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Blood-Brain Barrier Transport Drugs Market Research Report 2017
1 Blood-Brain Barrier Transport Drugs Market Overview
    1.1 Product Overview and Scope of Blood-Brain Barrier Transport Drugs
    1.2 Blood-Brain Barrier Transport Drugs Segment by Type (Product Category)
        1.2.1 Global Blood-Brain Barrier Transport Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Blood-Brain Barrier Transport Drugs Production Market Share by Type (Product Category) in 2016
        1.2.3 Carrier-mediated Transport
        1.2.4 Receptor-mediated Transport
        1.2.5 Absorptive-mediated Transport
        1.2.6 Active Efflux Transport
        1.2.7 Others
    1.3 Global Blood-Brain Barrier Transport Drugs Segment by Application
        1.3.1 Blood-Brain Barrier Transport Drugs Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Alzheimer's Disease
        1.3.3 Epilepsy
        1.3.4 Parkinson's Disease
        1.3.5 Multiple Sclerosis
        1.3.6 Hunter's Syndrome
        1.3.7 Brain Cancer
        1.3.8 Others
    1.4 Global Blood-Brain Barrier Transport Drugs Market by Region (2012-2022)
        1.4.1 Global Blood-Brain Barrier Transport Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Blood-Brain Barrier Transport Drugs (2012-2022)
        1.5.1 Global Blood-Brain Barrier Transport Drugs Revenue Status and Outlook (2012-2022)
        1.5.2 Global Blood-Brain Barrier Transport Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Blood-Brain Barrier Transport Drugs Market Competition by Manufacturers
    2.1 Global Blood-Brain Barrier Transport Drugs Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Blood-Brain Barrier Transport Drugs Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Blood-Brain Barrier Transport Drugs Production and Share by Manufacturers (2012-2017)
    2.2 Global Blood-Brain Barrier Transport Drugs Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Blood-Brain Barrier Transport Drugs Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Blood-Brain Barrier Transport Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Blood-Brain Barrier Transport Drugs Market Competitive Situation and Trends
        2.5.1 Blood-Brain Barrier Transport Drugs Market Concentration Rate
        2.5.2 Blood-Brain Barrier Transport Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Blood-Brain Barrier Transport Drugs Capacity and Market Share by Region (2012-2017)
    3.2 Global Blood-Brain Barrier Transport Drugs Production and Market Share by Region (2012-2017)
    3.3 Global Blood-Brain Barrier Transport Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Blood-Brain Barrier Transport Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Blood-Brain Barrier Transport Drugs Consumption by Region (2012-2017)
    4.2 North America Blood-Brain Barrier Transport Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Blood-Brain Barrier Transport Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China Blood-Brain Barrier Transport Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Blood-Brain Barrier Transport Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Blood-Brain Barrier Transport Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India Blood-Brain Barrier Transport Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Blood-Brain Barrier Transport Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Blood-Brain Barrier Transport Drugs Production and Market Share by Type (2012-2017)
    5.2 Global Blood-Brain Barrier Transport Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global Blood-Brain Barrier Transport Drugs Price by Type (2012-2017)
    5.4 Global Blood-Brain Barrier Transport Drugs Production Growth by Type (2012-2017)

6 Global Blood-Brain Barrier Transport Drugs Market Analysis by Application
    6.1 Global Blood-Brain Barrier Transport Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global Blood-Brain Barrier Transport Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Blood-Brain Barrier Transport Drugs Manufacturers Profiles/Analysis
    7.1 Cyclenium
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 BioAdvance
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 EIP Pharma
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Bioasis
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Bioasis Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Immune Pharmaceuticals
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 AZ Therapies
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Palobiofarma
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Bach Pharma
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 BrainsGate
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 CarThera
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 CarThera Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Dainippon Sumitomo Pharma
    7.12 Fluorinov Pharma
    7.13 Fondazione Telethon
    7.14 Minoryx
    7.15 NewGen Therapeutics

8 Blood-Brain Barrier Transport Drugs Manufacturing Cost Analysis
    8.1 Blood-Brain Barrier Transport Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Blood-Brain Barrier Transport Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Blood-Brain Barrier Transport Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Blood-Brain Barrier Transport Drugs Market Forecast (2017-2022)
    12.1 Global Blood-Brain Barrier Transport Drugs Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Blood-Brain Barrier Transport Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Blood-Brain Barrier Transport Drugs Price and Trend Forecast (2017-2022)
    12.2 Global Blood-Brain Barrier Transport Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Blood-Brain Barrier Transport Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Blood-Brain Barrier Transport Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Blood-Brain Barrier Transport Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Blood-Brain Barrier Transport Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Blood-Brain Barrier Transport Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Blood-Brain Barrier Transport Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Blood-Brain Barrier Transport Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Blood-Brain Barrier Transport Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer